Skip to content

Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00709787
Enrollment
899
Registered
2008-07-03
Start date
2008-06-30
Completion date
2009-02-28
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Epidemiology, hypertension, risk factors, coronary heart disease, patient management, compliance with medication

Brief summary

To assess the pattern of hypertension in the population in terms of presence of additional risk factors (ARF) and cardiovascular risk stratification.

Detailed description

routine physician visits

Interventions

OTHERUsual Care

Normal care for hypertensive patients with risk factors for CHD

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 80 years old * Patients with hypertension: newly diagnosed and /or already diagnosed and treated , whether at goal or not for the blood pressure level; * Patients with no history of CHD/CVD

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Description of hypertensive patients in terms of presence of associated cardiovascular (CV) risk factors (number of additional CV risk factors and frequency)

Secondary

MeasureTime frame
Description of pattern of management of HT and CVD prevention, through lifestyle and use of drug therapies,
Estimate adherence to treatment using the Morisky Adherence Scale (MAS)
Estimation of hypertensive patients CV risk stratification based on ESH/ESC Hypertension Guidelines 2007 and to compare it with physicians' estimation of CV risk.

Countries

Croatia, Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026